Viewing Study NCT07040059


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-02-02 @ 12:03 AM
Study NCT ID: NCT07040059
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2025-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Sponsor: Aurigene Discovery Technologies Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER 2 Positive Gastric Cancer View
None Gastroesophageal Junction Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BHARAT 2 View